Paxlovid is an antiviral administered orally to patients who are ill with COVID-19 or have been exposed to the coronavirus SARS-CoV-2 and are at risk of developing severe illness. The manufacturer, pharmaceutical and biotechnology giant Pfizer, developed it to patients avoid severe illness which can lead to hospitalization and death. It is meant to be administered at the first sign of infection.
Molnupiravir is an orally administered antiviral medication that inhibits the replication of certain RNA viruses, and is used to treat COVID-19.
The potential of neuroprotective agents for a whole new form of treatment.
A list of medicines TheSocialMedwork will soon be making available.
Darzalex (daratumumab) combination under review as first-line option.
The PBS, Australia’s national program responsible for providing subsidised prescriptions, has announced the addition of several new medicines
The FDA approval of a promising new drug is offering new hope to multiple myeloma patients who have already been through various treatments.
A new treatment that targets a specific type of lung cancer has received FDA approval.
